Cargando…
Persistent pharmacokinetic challenges to pediatric drug development
The development of new therapeutic agents for the mitigation of pediatric disorders is largely hindered by the inability for investigators to assess pediatric pharmacokinetics (PK) in healthy patients due to substantial safety concerns. Pediatric patients are a clinical moving target for drug delive...
Autores principales: | Sage, Daniel P., Kulczar, Christopher, Roth, Wyatt, Liu, Wanqing, Knipp, Gregory T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145254/ https://www.ncbi.nlm.nih.gov/pubmed/25221567 http://dx.doi.org/10.3389/fgene.2014.00281 |
Ejemplares similares
-
Pharmacogenomics of acetaminophen in pediatric populations: a moving target
por: Krasniak, Anne E., et al.
Publicado: (2014) -
Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting Challenges
por: Green, Steven D., et al.
Publicado: (2020) -
The Challenges of Pediatric Drug Development
por: Rose, Klaus
Publicado: (2019) -
Non-Coding RNAs in Pediatric Solid Tumors
por: Smith, Christopher M., et al.
Publicado: (2019) -
Does Cannabis Intake Protect Against Non-alcoholic Fatty Liver Disease? A Two-Sample Mendelian Randomization Study
por: Wang, Xiaokun, et al.
Publicado: (2020)